A detailed history of First Horizon Advisors, Inc. transactions in Elanco Animal Health Inc stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 579 shares of ELAN stock, worth $8,354. This represents 0.0% of its overall portfolio holdings.

Number of Shares
579
Holding current value
$8,354
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

BUY
$14.37 - $16.46 $8,320 - $9,530
579 New
579 $9,000
Q2 2023

Aug 03, 2023

SELL
$8.08 - $10.37 $5,486 - $7,041
-679 Reduced 85.73%
113 $1,000
Q1 2023

May 15, 2023

SELL
$8.79 - $14.58 $1,555 - $2,580
-177 Reduced 18.27%
792 $7,000
Q4 2022

Feb 10, 2023

BUY
$11.49 - $13.65 $9,835 - $11,684
856 Added 757.52%
969 $11,000
Q3 2022

Nov 09, 2022

SELL
$12.41 - $32.42 $4,318 - $11,282
-348 Reduced 75.49%
113 $1,000
Q2 2022

Aug 02, 2022

SELL
$19.63 - $26.62 $20,199 - $27,391
-1,029 Reduced 69.06%
461 $9,000
Q1 2022

May 10, 2022

BUY
$24.65 - $29.0 $8,898 - $10,469
361 Added 31.98%
1,490 $39,000
Q4 2021

Feb 09, 2022

SELL
$27.74 - $34.09 $388 - $477
-14 Reduced 1.22%
1,129 $32,000
Q3 2021

Nov 09, 2021

BUY
$29.2 - $36.72 $33,375 - $41,970
1,143 New
1,143 $36,000
Q1 2021

May 11, 2021

SELL
$27.85 - $34.49 $33,559 - $41,560
-1,205 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$21.1 - $29.13 $6,963 - $9,612
-330 Reduced 21.5%
1,205 $33,000
Q2 2020

Jul 31, 2020

SELL
$18.94 - $24.93 $852 - $1,121
-45 Reduced 2.85%
1,535 $32,000
Q1 2020

May 05, 2020

BUY
$16.68 - $32.25 $8,423 - $16,286
505 Added 46.98%
1,580 $35,000
Q3 2019

Oct 23, 2019

BUY
$25.62 - $34.96 $4,611 - $6,292
180 Added 20.11%
1,075 $28,000
Q2 2019

Aug 05, 2019

SELL
$31.11 - $34.79 $31 - $34
-1 Reduced 0.11%
895 $0
Q1 2019

Apr 26, 2019

BUY
$29.0 - $32.83 $25,984 - $29,415
896 New
896 $0

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.84B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.